Sandoz plans to spend more than $175 million to develop and outfit its European hub for antibiotics manufacturing in Kundl, Austria with new technology. The investment, which will occur over a five-year period, comes from both Sandoz and the Austrian government and is meant to strengthen Europe’s competitive position for manufacturing key antibiotics. For its part, the Austrian government will contribute roughly $60 million which will be earmarked for technology used in the manufacture of the API’s associated with penicillin products. Learn More